Answers are grounded in this paper and cite their sources.
demonstrated improvement in local recurrence [6,7].Despite that, other studies reported that around one-fifth of the cases will have no response to RT.Other workers reported that the contribution of neoadjuvant RT to pathological complete response in terms of survival was of limited or minimal benefit [8].In view of the above changes, the real challenge in rectal cancer treatment is to identify patients who would fully benefit from the new treatment protocols which involve RT.The aim of this article is to present the different histological systems used to classify the response rate of the patients and to discuss the different types of biomarkers used to predict of the response of patients to RT/ chemoradiotherapy (CRT). RT Mechanism of ActionOxidative stress damage is extensive in cells exposed to ionising radiation.This damage mainly targets nuclear DNA through inhib-The management of rectal cancer is a major undertaking.There are currently multiple treatment modalities with variable degrees of complications.Radiotherapy (RT) is one of the more frequently used modalities either on its own or more frequently with chemotherapy mostly before the definitive surgery.The outcome of RT is unpredictable.RT has its serious side effects and there are no guarantees of its usefulness in all patients.This article outlines the effect of RT on the tumor, reviews the various staging systems of responses to RT and present recent evidence of which case is less responsive to such treatments to avoid unnecessary complications.
No takes yet. Share an insight, caveat, or question.
Alqudah et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: